rs4254-cowen_rodman.htm


Filed by Rodman & Renshaw Capital  Group, Inc.
Pursuant to Rule 425 under the Securities Act of 1933
and deemed filed pursuant to Rule 14a-12
of the Securities Exchange Act of 1934
Subject Company:  Cowen Group, Inc.
Commission File No.:  001-33737


This filing relates to a proposed business combination between Rodman & Renshaw Capital Group, Inc. (“Rodman”) and Cowen Group, Inc. (“Cowen”).

This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval.  This material is not a substitute for the prospectus/proxy statement Rodman would file with the SEC if an agreement between Rodman and Cowen is reached or any other documents which Rodman may file with the Securities and Exchange Commission (“SEC”) and send to Cowen and Rodman shareholders in connection with the proposed transaction.  INVESTORS AND SECURITY HOLDERS OF COWEN AND RODMAN ARE URGED TO READ ANY SUCH DOCUMENTS FILED WITH THE SEC CAREFULLY IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION.

Investors and security holders will be able to obtain free copies of any documents filed with the SEC by Rodman through the website maintained by the SEC at www.sec.gov.  Free copies of any such documents can also be obtained by accessing the Investor Relations section of Rodman’s website at www.rodm.com or directing a request to Investor Relations, Rodman & Renshaw Capital Group, Inc., 1251 Avenue of the Americas, New York, New York  10020.

Rodman and its directors and executive officers and other persons may be deemed to be participants in the solicitation of proxies in respect of the proposed transaction.  Information regarding Rodman’s directors and executive officers is available in its Annual Report on Form 10-K for the year ended December 31, 2007, which was filed with the SEC on March 14, 2008, and its proxy statement for its 2008 annual meeting of stockholders, which was filed with the SEC on October 1, 2008.  Other information regarding the participants in a proxy solicitation and a description of their direct and indirect interests, by security holdings or otherwise, will be contained in any proxy statement/prospectus filed in connection with the proposed transaction.

Statements in this communication that are “forward-looking statements” are based on current expectations and assumptions that are subject to risks and uncertainties.  Actual results could differ materially because of factors such as Rodman’s ability to achieve the synergies and value creation contemplated by the proposed transaction, Rodman’s ability to promptly and effectively integrate the businesses of Rodman and Cowen, the timing to consummate the proposed transaction and any necessary actions to obtain required regulatory approvals, and the diversion of management time on transaction-related issues.  For further information regarding risks and uncertainties associated with Rodman’s business, please refer to the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Risk Factors” sections of Rodman’s SEC filings, including, but not limited to, its annual report on Form 10-K and quarterly reports on Form 10-Q, copies of which may be obtained by contacting Rodman’s Investor Relations department at (212) 356-0500 or at Rodman’s website at http://www.rodm.com.

All information in this communication is as of the date hereof.  Rodman undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the company’s expectations.


# # #

INVESTOR PRESENTATION DATED DECEMBER 15, 2008
 

 


December 15, 2008
Proposed Merger with Cowen Group, Inc.
Creating the Leading Investment Bank for Growth Companies
 
 

 
1
Disclaimers
Forward-Looking Statements
This presentation includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
These forward-looking statements include, for example, statements regarding the expected timetable for the proposed
transaction, benefits and synergies of the proposed merger, integration plans, future opportunities for the combined company,
and any other statements regarding future expectations, beliefs, goals or prospects. There are a number of risks and uncertainties
that could cause actual results to differ materially from the forward-looking statements made herein. The factors that could cause
actual results to differ materially from these forward-looking statements include the ability to achieve the benefits and synergies
contemplated by the proposed transaction, the ability to promptly and effectively integrate the businesses of Rodman & Renshaw
Capital Group, Inc. (“Rodman”) and Cowen Group, Inc. (“Cowen”), and the timing to consummate the proposed transaction and
obtain required regulatory approvals, including, but not limited to, those discussed in (1) Rodman’s Annual Report on Form 10-K
for the year ended 12/31/07 in (a) ITEM 1A. Risk Factors, (b) ITEM 7. Management’s Discussion and Analysis of Financial Condition
and Results of Operations and (c) ITEM 8. Financial Statements and Supplementary Data: Note 10; (2) Rodman’s Quarterly Report
on Form 10-Q for the quarter ended 06/30/08 in (a) Part II, Other Information, ITEM 1A. Risk Factors and (b) Part I, Financial
Information, ITEM 1. Financial Statements: Note 7; (3) Rodman’s Quarterly Report on Form 10-Q for the quarter ended 09/30/08
(to be in (a) Part II, Other Information, ITEM 1A. Risk Factors and (b) Part I, Financial Information, ITEM 1. Financial Statements:
Note 7; and (4) other factors discussed in Rodman’s filings with the Securities and Exchange Commission (“SEC”), copies of which
may be obtained by contacting Rodman’s Investor Relations department at (212) 356-0500 or at Rodman’s website at
www.rodm.com. Readers are cautioned not to place undue reliance on these forward-looking statements, which apply only as of
the date of this filing. Rodman does not undertake any obligation to publicly release any revision to its forward-looking statements
to reflect events or circumstances after the date of this filing.
Securities Law
This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any
vote or approval. This material is not a substitute for the prospectus/proxy statement Rodman would file with the SEC if an
agreement between Rodman and Cowen is reached or any other documents which Rodman may file with the SEC and send to
Cowen and/or Rodman stockholders in connection with the proposed transaction. 
Investors and security holders of Cowen and
Rodman are urged to read any such documents filed with the SEC carefully in their entirety when they become available
because they will contain important information about the proposed transaction
.
Pro Forma, Estimated, Third Party and Consensus Information
The pro forma, estimated, third party or consensus numbers in this presentation are for illustrative purposes only and may not
reflect actual results.  The analysts' opinions, estimates or forecasts (and therefore the consensus earnings and pro forma
numbers) are theirs alone, are not those of Rodman, and shall not be deemed to be, or relied upon as, Rodman guidance or
estimates.  As a matter of policy, Rodman does not publish guidance or estimates or comment on analyst models and the use of
this information in this presentation shall not be deemed in any manner to constitute Rodman's adoption of any analyst guidance
or estimates or confirmation of the validity of any analyst model.
 
 

 
2
 By exploiting identified macro-trends, Rodman has continued to expand its PIPEs platform
 Our strategy:
 § Continue to grow in our core sectors
 § Expand our product base
 § Broaden our geographic footprint
 § Broaden our potential sources of revenue
 § Remain focused on expense management
 Offices in New York, Boston, Houston, Calgary, and affiliate in London
 Acquisitions in 2008 to broaden sector coverage (energy and metals & mining), continue to
 diversify products and revenue sources (M&A and capital markets), and expand geographic
 footprint
Rodman & Renshaw Capital Group, Inc. (NASDAQ: RODM)
A full service investment bank dedicated to providing investment banking services to growth
companies that have significant recurring capital needs
 
 

 
3
Rodman Financial Highlights
Despite the Economic Environment, Rodman Was Profitable in 2007 and Year to Date 09/30/08
Nine months ended 09/30/08 Highlights
 22% operating margin despite adverse market conditions(1,2)
 45% compensation ratio due to our variable compensation structure which aligns producer
 compensation with productivity and performance
(1)
 33% non-compensation ratio due to our prudent cash management and expense control policies(2)
Strong Balance Sheet with No Exposure to Toxic Financial Assets
 Liquid assets of $31.9 million as of 09/30/08, consisting of unrestricted cash, restricted cash, Level 1
 assets, and current private placement and other fees receivable and due from clearing broker
(1) Excludes the cost related to pre-IPO awards
(2) Excludes goodwill impairment charge
 
 

 
4
Comparable Industry Financial Results
 
 

 
Rodman’s Cost Management Compared to Our Peers
5
Cost as a Percentage of Revenue
Nine Months Ended 09/30/08
 
 

 
6
 Cowen’s sector and market cap focus compared to Rodman’s
 § Shared healthcare focus
  Little overlap with Rodman’s healthcare banking and research coverage
 § Cowen’s other target sectors complement Rodman’s non-healthcare focus on energy and
 metals/mining:
  Aerospace & Defense
  Alternative Energy
  Consumer
  Technology
  Telecommunications
 Meaningful presence on West Coast, Asia, and Europe
 § Complementary to Rodman’s geographic footprint
 Focus on cash equities/research franchise (low margins), equity capital markets; substantial decline in
 once-profitable PIPEs franchise
 Strong, liquid balance sheet deteriorating due to recurring losses
 § Cash balance of approximately $111.9 million, as of 09/30/08, less $34.7 million accrued for bonus
 payments
(1)
 § Persistent losses are steadily draining cash: $38.1 million net operating cash outflows between
 01/01/07 and 09/30/08
(2)
 § Current market valuation/analysts’ estimates reflect expectation of indefinite continuing net cash
 outflows
Cowen Group, Inc. (NASDAQ: COWN)
(1) Cowen’s Quarterly Report on Form 10-Q for the period ended 09/30/08 as filed with the SEC
(2) Cowen’s SEC filings
 
 

 
7
Cowen’s PIPE Practice (2004 - 2008 Annualized)
Cowen’s PIPE practice has declined substantially, even though PIPEs are a growing, profitable and counter-
cyclical product attractive to Cowen’s target sectors
 
 

 
8
Revenue Impact of Cowen’s Recent PIPEs Performance
Cowen’s Investment Banking Revenue and PIPE Allocation
 
 

 
9
Strategic Benefits of the Proposed Combination
Broad Sector Coverage for Combined Firm
 Market leader in Life Science / Healthcare
 Expanded platform in Alternative Energy, Metals & Mining, and Energy
 Retained presence in Consumer, Aerospace & Defense and TMT
Product and Revenue Expansion
 Restore PIPEs revenue to Cowen’s existing Healthcare client base
 Drive PIPEs revenue in new sectors
 Enhanced capital markets, research, sales and trading services across Rodman’s existing client base
Geographic Footprint
 Expanded footprint within North America through offices in Houston, Calgary and superior West Coast
 coverage
 Leverage Cowen’s infrastructure in Asia and Europe with existing Rodman relationships and pipeline
Reap the benefits of combined Finance, Mergers & Acquisitions, Research and Sales & Trading platforms
Principal investment activities are complementary with no overlap
 
 

 
10
Benefits of Implementing Rodman’s Model to Expense Management
 Change mindset by bringing in a management team with meaningful equity stake
 § Increased alignment of interest between management and stockholders
 Remove layers of redundant staff and management
 Align producer compensation with productivity and performance
 Migrate Rodman’s approach to non-compensation expense
 § IT
 § Business development
 § Data management
 Improve cash management and expense control
 
 

 
11
Summary of Proposal, Financial Assumptions and Conditions to Closing
Proposal price:
 $7.00 per share
Consideration:
 50% cash / 50% stock for all outstanding shares of Cowen common stock
Cost savings:
 Annual cost savings of approximately $36.5 million in 2009 and $38.4 million in
 2010
Income
enhancements:
 Contribution from revenue enhancements expected to generate $18.0 million of
 pro-forma pretax income for 2009 with 12% growth thereafter
Conditions to
closing:
 Due diligence
 Definitive merger agreement
 Regulatory approval - - HSR and typical broker / dealer
 Stockholder approval - - Rodman and Cowen
 
 

12
Pro Forma Assumptions
Transaction close:
 February 28, 2009
Share price:
 Based on Rodman’s closing share price of $1.18, as of Monday, December 8, 2008
EPS estimates (1)
 I/B/E/S net income and EPS estimates based on 2009 consensus estimates as
 published by Thomson Reuters
 Net income and EPS projected at a long-term growth rate of 12% in 2010
(1) Applies to both Rodman and Cowen
 
 

 
 
 
13
Financing
Net Share Settlement Convertible Note
 Principal ($50mm) settled in cash
 Conversion spread settled in common stock
 § Treasury stock method - beneficial EPS impact
 Coupon less than 7%
 Modest conversion premium of more than 10%
 Limited warrant coverage
 Term - two years or less
Other Financing Option(s)
 Following public announcement of proposal on December 8, 2008, substantial expressions of interest in
 strategic common equity investment into Rodman, which could provide all or part of required financing
Proposed financing facilitates meaningfully accretive transaction, with modest debt service and healthy,
liquid balance sheet post-combination
 
 

 
14
Estimated Transaction Cost Savings
 
 

 
15
Accretion-Dilution
 
 

 
16
Pro Forma Balance Sheet (1)
 
 

 
17
Appendix: Rodman Historical Income Statement
 
 

 
New York:
1251 Avenue of the Americas
20th Floor
New York, NY 10020
212.356.0500 
Member FINRA, SIPC
Houston:
1001 Fannin
Suite 550
Houston, TX 77002
713.654.8080
Calgary: 
304 - 8th Avenue SW
Suite 501
Calgary, AB T2P 1C2
403.237.9462
Boston:
225 Franklin Street
26th Floor
Boston, MA 02110
617.217.2215
London (affiliated firm, RCP): 
One Great Cumberland Place
London W1H 7AL
United Kingdom
+44.20.7569.0044
www.rodm.com